|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02396004 |
|
Date of registration:
|
18/03/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
NIRS in PDA VLBW Infants
|
|
Scientific title:
|
Near-Infrared Red Spectroscopy (NIRS) to Measure Cerebral Perfusion During and After Patent Ductus Arteriosus (PDA) Treatment in Very Low Birth Weight (VLBW) Infants |
|
Date of first enrolment:
|
October 2014 |
|
Target sample size:
|
30 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02396004 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Singapore
| | | | | | | |
|
Contacts
|
|
Name:
|
Woei Bing Poon, MRCPCH |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Singapore General Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- VLBW infants with hemodynamically significant PDA by echocardiography
Exclusion Criteria:
- Major malformation
- Moribund
Age minimum:
N/A
Age maximum:
6 Months
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
PDA
|
|
Intervention(s)
|
|
Device: Near Infrared Red Spectroscopy (NIRS)
|
|
Primary Outcome(s)
|
|
cerebral oximetry
[Time Frame: 2 years]
|
|
Secondary Outcome(s)
|
|
renal oximetry
[Time Frame: 2 years]
|
|
Secondary ID(s)
|
|
CIRB 2013/379/E
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|